Literature DB >> 25488716

No increased bleeding risk for oral surgery in patients with severe congenital bleeding disorders due to intense perioperative management.

G Goldmann1, C Berens, N Marquardt, R Reich, J Oldenburg, M Wenghoefer.   

Abstract

PURPOSE: In order to evaluate complication rates of dentoalveolar surgery in patients with congenital bleeding disorders, a retrospective case-control study was performed.
METHODS: A collective of patients with congenital bleeding disorders (n = 69), who received common oral surgery procedures in combination with intense perioperative monitoring and coagulation factor substitution at the University Hospital of Bonn between 1992 and 2011, was matched with patients without bleeding disorders by age, sex, and type of surgery. In addition to the rates of perioperative bleeding and other complications, the duration of surgery and the use of local hemostatic agents were compared between both cohorts.
RESULTS: There were no significant differences between the two groups regarding the rate of postoperative bleeding (2.9 vs. 1.4%, patients with congenital bleeding disorders vs controls) and the rate of other complications (7.2 vs. 21.7%). Furthermore, no significant difference in operation time (54 min in patients with congenital bleeding disorders vs 45 min in controls) was observed. However, there was a significant difference (p < 0.001) regarding the use of local hemostatic measures, which were applied in all patients with hereditary bleeding disorders but in only one of the controls. All patients with bleeding disorders were inpatients, while all controls were treated in an outpatient setting.
CONCLUSIONS: If adequate measures are taken, the complication rate following oral surgery in patients with hereditary bleeding disorders can be reduced to that of patients without bleeding disorders. However, these results are reached at significant costs due to coagulation factor replacement and inpatient treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25488716     DOI: 10.1007/s10006-014-0476-z

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  20 in total

Review 1.  Primary dental care of patients with haemophilia.

Authors:  B Harrington
Journal:  Haemophilia       Date:  2000-07       Impact factor: 4.287

2.  Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia a patient with inhibitor.

Authors:  Yoshinari Morimoto; Akira Yoshioka; Midori Shima; Tadaaki Kirita
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

3.  Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report.

Authors:  Max Heiland; Martin Weber; Rainer Schmelzle
Journal:  J Oral Maxillofac Surg       Date:  2003-11       Impact factor: 1.895

4.  Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate.

Authors:  Ezio Zanon; Barbara Brandolin; Graziella Saggiorato; Christian Bacci
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

5.  Treatment of odontogenic large cysts in haemophiliac patients.

Authors:  Onur Cakr; Hakk O Kazancoğlu; Gülsüm Ak; Bülent Zülfikar
Journal:  Blood Coagul Fibrinolysis       Date:  2012-04       Impact factor: 1.276

6.  Hemophilia: Problem of Surgical Intervention for Accompanying Diseases. Review of the Literature and Report of a Case.

Authors:  C G Craddock; L D Fenninger; B Simmons
Journal:  Ann Surg       Date:  1948-11       Impact factor: 12.969

7.  [Morbidity and mortality of patients with haemophilia in Germany--update 2010/2011].

Authors:  W Schramm; A Rieger
Journal:  Hamostaseologie       Date:  2012       Impact factor: 1.778

8.  Moynihan Lecture, 1980. Major surgery in haemophilia.

Authors:  W J Rudowski
Journal:  Ann R Coll Surg Engl       Date:  1981-03       Impact factor: 1.891

9.  Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B.

Authors:  I D Hewson; P Makhmaloaf
Journal:  Aust Dent J       Date:  2010-09       Impact factor: 2.291

10.  Urological surgery in patients with hemorrhagic bleeding disorders Hemophilia A, Hemophilia B, von Willebrand disease: a retrospective study with matched pairs analysis.

Authors:  Sebastian Rogenhofer; Stefan Hauser; Anne Breuer; Guido Fechner; Stefan C Mueller; Johannes Oldenburg; Georg Goldmann
Journal:  World J Urol       Date:  2012-11-21       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.